350 related articles for article (PubMed ID: 26935838)
1. FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion.
Kalhori V; Magnusson M; Asghar MY; Pulli I; Törnquist K
Endocr Relat Cancer; 2016 May; 23(5):457-68. PubMed ID: 26935838
[TBL] [Abstract][Full Text] [Related]
2. MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells.
Kalhori V; Törnquist K
Mol Cell Endocrinol; 2015 Mar; 404():113-22. PubMed ID: 25643979
[TBL] [Abstract][Full Text] [Related]
3. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
Butler J; Lana D; Round O; LaMontagne K
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2.
Patmanathan SN; Johnson SP; Lai SL; Panja Bernam S; Lopes V; Wei W; Ibrahim MH; Torta F; Narayanaswamy P; Wenk MR; Herr DR; Murray PG; Yap LF; Paterson IC
Sci Rep; 2016 May; 6():25650. PubMed ID: 27160553
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate attenuates MMP2 and MMP9 in human anaplastic thyroid cancer C643 cells: Importance of S1P2.
Asghar MY; Kemppainen K; Lassila T; Törnquist K
PLoS One; 2018; 13(5):e0196992. PubMed ID: 29734379
[TBL] [Abstract][Full Text] [Related]
7. Molecular targets of FTY720 (fingolimod).
Pitman MR; Woodcock JM; Lopez AF; Pitson SM
Curr Mol Med; 2012 Dec; 12(10):1207-19. PubMed ID: 22834825
[TBL] [Abstract][Full Text] [Related]
8. To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling.
Chew WS; Wang W; Herr DR
Pharmacol Res; 2016 Nov; 113(Pt A):521-532. PubMed ID: 27663260
[TBL] [Abstract][Full Text] [Related]
9. [Effects of sphingosine 1-phosphate on functions of T cell - review].
Huang WR; Wang LS; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries.
Hamidi Shishavan M; Bidadkosh A; Yazdani S; Lambooy S; van den Born J; Buikema H; Henning RH; Deelman LE
PLoS One; 2016; 11(9):e0162029. PubMed ID: 27583547
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate induces the migration of thyroid follicular carcinoma cells through the microRNA-17/PTK6/ERK1/2 pathway.
Zhao S; Li J
PLoS One; 2015; 10(3):e0119148. PubMed ID: 25748447
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine 1-phospate differentially modulates maturation and function of human Langerhans-like cells.
Bock S; Pfalzgraff A; Weindl G
J Dermatol Sci; 2016 Apr; 82(1):9-17. PubMed ID: 26803226
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.
Tiper IV; East JE; Subrahmanyam PB; Webb TJ
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27354294
[TBL] [Abstract][Full Text] [Related]
15. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Ottenlinger F; Schwiebs A; Pfarr K; Wagner A; Grüner S; Mayer CA; Pfeilschifter JM; Radeke HH
Eur J Immunol; 2016 Apr; 46(4):941-51. PubMed ID: 26683421
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.
Katsuta E; Yan L; Nagahashi M; Raza A; Sturgill JL; Lyon DE; Rashid OM; Hait NC; Takabe K
J Surg Res; 2017 Nov; 219():202-213. PubMed ID: 29078883
[TBL] [Abstract][Full Text] [Related]
17. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
[TBL] [Abstract][Full Text] [Related]
18. Transient Receptor Potential Canonical 1 (TRPC1) Channels as Regulators of Sphingolipid and VEGF Receptor Expression: IMPLICATIONS FOR THYROID CANCER CELL MIGRATION AND PROLIFERATION.
Asghar MY; Magnusson M; Kemppainen K; Sukumaran P; Löf C; Pulli I; Kalhori V; Törnquist K
J Biol Chem; 2015 Jun; 290(26):16116-31. PubMed ID: 25971967
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Oo ML; Thangada S; Wu MT; Liu CH; Macdonald TL; Lynch KR; Lin CY; Hla T
J Biol Chem; 2007 Mar; 282(12):9082-9. PubMed ID: 17237497
[TBL] [Abstract][Full Text] [Related]
20. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
Kihara A; Igarashi Y
Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
